Edition:
United States

Bio Path Holdings Inc (BPTH.OQ)

BPTH.OQ on NASDAQ Stock Exchange Capital Market

1.57USD
13 Jul 2018
Change (% chg)

$0.04 (+2.61%)
Prev Close
$1.53
Open
$1.50
Day's High
$1.63
Day's Low
$1.50
Volume
6,880
Avg. Vol
39,822
52-wk High
$5.85
52-wk Low
$1.25

Chart for

About

Bio-Path Holdings, Inc. is a clinical and preclinical stage oncology focused antisense drug development company. The Company utilizes a technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease. Its drug delivery and antisense technology, DNAbilize,... (more)
No analyst recommendations are available for .

Overall

Beta: 2.94
Market Cap(Mil.): $17.80
Shares Outstanding(Mil.): 11.34
Dividend: --
Yield (%): --

Financials

  BPTH.OQ Industry Sector
P/E (TTM): -- 214.97 33.20
EPS (TTM): -0.92 -- --
ROI: -108.97 -3.79 13.23
ROE: -133.36 -5.32 15.28

BRIEF-Bio-Path Holdings Reports Q1 Loss Per Share $0.17

* BIO-PATH HOLDINGS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

May 16 2018

BRIEF-Bio-Path Holdings Reports Full Year 2017 Financial Results

* PATH HOLDINGS REPORTS FULL YEAR 2017 FINANCIAL RESULTS Source text for Eikon: Further company coverage:

Apr 03 2018

BRIEF-Bio Path Holdings Says Board Increased Its Size From Four Members To Five Members

* BIO PATH HOLDINGS INC SAYS ON FEB 1, 2018, BOARD OF CO, INCREASED ITS SIZE FROM FOUR MEMBERS TO FIVE MEMBERS - SEC FILING Source text: [http://bit.ly/2GQ9Xup] Further company coverage:

Feb 05 2018

Earnings vs. Estimates